Medicine and Dentistry
Patient
84%
Cohort Analysis
78%
Atrial Fibrillation
68%
Inpatient
63%
Apoplexy
43%
Venous Thromboembolism
39%
Antithrombotic
31%
Therapeutic Procedure
23%
Heart Failure
20%
Hazard Ratio
19%
Anticoagulant Therapy
19%
Retina Artery Occlusion
18%
Thromboembolism
16%
Female
12%
Bleeding
12%
Diet and Cancer
12%
Death
12%
Anticoagulation
12%
Mortality
11%
Health
11%
Age
11%
Woman
10%
Major Bleeding
10%
CHA2DS2-VASc Score
10%
Malignant Neoplasm
10%
Arteriosclerosis Obliterans
10%
Diagnosis
10%
Development
9%
Rivaroxaban
9%
Warfarin
9%
Vitamin K Antagonist
9%
Person
8%
Analysis
8%
Brain Ischemia
8%
Follow up
8%
Association
8%
Death
7%
Adverse Event
7%
Complication
6%
Hospital
6%
Cerebral Hemorrhage
6%
All Cause Mortality
6%
Revascularization
6%
Risk Stratification
6%
Retina Vein Occlusion
6%
Secondary Prevention
6%
Patient with Cancer
6%
Introspection
6%
Pregnancy
6%
Direct Oral Anticoagulant
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Atrial Fibrillation
50%
Anticoagulant Agent
22%
Warfarin
17%
Dabigatran
15%
Rivaroxaban
15%
Direct Oral Anticoagulant
15%
Venous Thromboembolism
12%
Bleeding
11%
Diseases
10%
Apixaban
8%
Antivitamin K
7%
Thromboembolism
7%
Malignant Neoplasm
6%
Brain Ischemia
5%